Q3 2013 Holdings
Filed 2013-11-14 | 26 holdings | $19.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $13.0M | 1,718,905 | 68.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $5.5M | 196,996 | 28.8% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $136.5K | 3,153,665 | 0.7% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $93.6K | 7,896,061 | 0.5% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $60.5K | 9,719,589 | 0.3% |
| Exelixis Inc | NOTE 4.250% 08/15/2019 | 30161QAC8 | $48.0K | $40,735,000 | 0.3% |
| Rigel Pharmaceuticals Inc(RIGLUSD) | COM NEW | 766559603 | $34.8K | 9,730,697 | 0.2% |
| Targacept Inc | COM | 87611R306 | $32.8K | 6,171,669 | 0.2% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $29.9K | 5,377,616 | 0.2% |
| Oncothyreon Inc | COM | 682324108 | $18.3K | 8,872,778 | 0.1% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $14.6K | 2,502,256 | 0.1% |
| Array Biopharma Inc | NOTE 3.000% 06/01/2020 | 04269XAA3 | $13.7K | $12,000,000 | 0.1% |
| Regado Biosciences Inc | COM | 75874Q107 | $11.1K | 1,659,091 | 0.1% |
| QLT Inc | COM | 746927102 | $11.0K | 2,370,263 | 0.1% |
| Avanir Pharmaceuticals Inc | CL A NEW | 05348P401 | $10.3K | 2,436,053 | 0.1% |
| Receptos Inc | COM | 756207106 | $8.3K | 320,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $8.3K | 545,372 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $6.8K | 2,935,187 | 0.0% |
| Pain Therapeutics Inc | COM | 69562K100 | $6.4K | 2,357,327 | 0.0% |
| Oncomed Pharmaceuticals Inc | COM | 68234X102 | $6.0K | 391,800 | 0.0% |
| Palatin Technologies Inc | COM PAR $ .01 | 696077403 | $3.5K | 5,200,000 | 0.0% |
| Sophiris BIO Inc | COM NEW | 83578Q209 | $2.8K | 600,000 | 0.0% |
| Anthera Pharmaceuticals Inc | COM NEW | 03674U201 | $2.3K | 559,624 | 0.0% |
| Regulus Therapeutics Inc | COM | 75915K101 | $2.2K | 233,689 | 0.0% |
| Genvec Inc | COM NEW | 37246C307 | $617 | 486,100 | 0.0% |
| Transcept Pharmaceuticals Inc | COM | 89354M106 | $477 | 150,000 | 0.0% |